STOCK TITAN

DaVita (NYSE: DVA) COO gets stock awards, uses shares for taxes

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

DaVita Inc. Chief Operating Officer David Paul Maughan reported equity compensation awards and related tax-withholding transactions. He received 14,351 stock appreciation rights tied to DaVita common stock at an exercise price of $150.7200 per share, expiring on March 15, 2031. He was also granted 5,308 shares of common stock as restricted stock units that are scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030, subject to award terms.

On the same date, DaVita withheld 5,339 shares and 7,768 shares of common stock to cover tax obligations on the vesting of earlier restricted stock unit grants from March 15, 2022 and March 15, 2023. These F-code dispositions are payments of tax liability, not open-market sales. After these transactions, Maughan directly owns 114,467 shares of DaVita common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Maughan David Paul

(Last) (First) (Middle)
C/O DAVITA INC.
2000 16TH STREET

(Street)
DENVER CO 80202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer, DKC
3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/15/2026 A 5,308(1) A $0 127,574(2) D
Common Stock 03/15/2026 F 5,339(3) D $150.72 122,235 D
Common Stock 03/15/2026 F 7,768(4) D $150.72 114,467 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Rights $150.72 03/15/2026 A 14,351 (5) 03/15/2031 Common Stock 14,351 $0 14,351 D
Explanation of Responses:
1. These restricted stock units are scheduled to vest 50% each on March 15, 2029 and March 15, 2030, respectively, subject to the terms and conditions of the applicable award agreement.
2. The number of shares reported include shares acquired under DaVita Employee Stock Purchase Plan, an exempt transaction pursuant to Rule 16b-3.
3. Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 12,203 shares, which represents 50% of the restricted stock units granted to the Reporting Person on March 15, 2022.
4. Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 17,754 shares, which represents 50% of the restricted stock units granted to the Reporting Person on March 15, 2023.
5. The stock appreciation rights are scheduled to vest 50% each on March 15, 2029 and March 15, 2030, respectively, subject to the terms and conditions of the applicable award agreement.
Remarks:
/s/ Stephanie N. Berberich, Attorney-in-Fact 03/17/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DaVita (DVA) COO David Paul Maughan report in this Form 4?

David Paul Maughan reported new equity compensation and tax-related share withholdings. He received stock appreciation rights and restricted stock units, while DaVita withheld shares to satisfy tax obligations on earlier RSU vestings, all on March 15, 2026.

How many DaVita (DVA) shares does David Paul Maughan hold after these transactions?

After the reported transactions, David Paul Maughan directly owns 114,467 shares of DaVita common stock. This figure reflects the net result after new stock awards and shares withheld to cover tax obligations tied to vesting restricted stock units.

What stock appreciation rights did DaVita (DVA) grant to its COO?

DaVita granted Maughan 14,351 stock appreciation rights linked to common stock at an exercise price of $150.7200 per share. These rights are scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030, and expire on March 15, 2031.

Were any DaVita (DVA) shares sold on the open market in this Form 4?

No open-market sales are reported. The dispositions coded “F” involve 5,339 and 7,768 shares withheld by DaVita to pay tax obligations from RSU vesting. These are tax-withholding transactions, not discretionary market sales by Maughan.

What restricted stock units did DaVita (DVA) grant to its COO in this filing?

Maughan was granted 5,308 shares of DaVita common stock as restricted stock units. These RSUs are scheduled to vest in two equal installments on March 15, 2029 and March 15, 2030, subject to the terms of the applicable award agreement.

Why did DaVita (DVA) withhold 13,107 shares from David Paul Maughan?

DaVita withheld 13,107 shares (5,339 plus 7,768) to cover tax obligations on vesting RSUs. These relate to 12,203 and 17,754 shares that vested from grants awarded on March 15, 2022 and March 15, 2023, respectively, representing 50% of each prior award.
Davita Inc

NYSE:DVA

View DVA Stock Overview

DVA Rankings

DVA Latest News

DVA Latest SEC Filings

DVA Stock Data

9.91B
33.19M
Medical Care Facilities
Services-misc Health & Allied Services, Nec
Link
United States
DENVER